ARTICLE | Clinical News
Lurbinectedin: Phase III started
July 13, 2015 7:00 AM UTC
PharmaMar began the open-label, international Phase III CORAIL trial to compare lurbinectedin vs. pegylated liposomal doxorubicin or topotecan in about 420 patients. PharmaMar is a subsidiary of Zelt...